Abvc Biopharma, Inc.
ABVC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173313
No open-market purchases or sales by Abvc Biopharma, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.72M in total; no superinvestor holds it.
Other share classesECOC
Q2 2023 vs. Q1 2023
How the institutions holding Abvc Biopharma, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 9 | 9 | 0 |
| Shares | 661.1K | 588.5K | −72.6K (−11.0%) |
| Value | $421.1K | $304.2K | −$116.9K (−27.8%) |
New holders (2)
Institutions that held Abvc Biopharma, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Spotlight Asset Group, Inc. | 1,000 | $520 | 0.00% |
| Royal Bank of Canada | 383 | $0 | 0.00% |
Sold out (2)
Institutions that held Abvc Biopharma, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Two Sigma Securities, LLC | 21,072 | $13.5K |
| Susquehanna International Group, LLP | 13,923 | $8.77K |